Search

Search Constraints

You searched for: Author/Creator Vis, André N.

Search Results

1. A systematic review on mutation markers for bladder cancer diagnosis in urine. (16th August 2020)

2. Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancer. (December 2019)

4. Predicting early outcomes in patients with intermediate‐ and high‐risk prostate cancer using prostate‐specific membrane antigen positron emission tomography and magnetic resonance imaging. (16th June 2021)

5. Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator. (March 2022)

6. Selection of patients for nerve sparing surgery in robot‐assisted radical prostatectomy. Issue 1 (9th November 2021)

7. Standardised uptake values as determined on prostate‐specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer. (12th March 2022)

8. The clinical characteristics of patients with primary non‐prostate‐specific membrane antigen‐expressing prostate cancer on preoperative positron emission tomography/computed tomography. (13th December 2021)

9. The effect of timing of an immediate instillation of mitomycin C after transurethral resection in 941 patients with non‐muscle‐invasive bladder cancer. (31st January 2018)

10. The prognostic value of lymph node staging with prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and extended pelvic lymph node dissection in node‐positive patients with prostate cancer. (17th September 2022)